Suven Pharmaceuticals consolidated net profit declines 0.41% in the June 2020 quarter

Capital Market 

Sales rise 20.69% to Rs 238.23 crore

Net profit of Suven Pharmaceuticals declined 0.41% to Rs 91.52 crore in the quarter ended June 2020 as against Rs 91.90 crore during the previous quarter ended June 2019. Sales rose 20.69% to Rs 238.23 crore in the quarter ended June 2020 as against Rs 197.39 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales238.23197.39 21 OPM %47.0551.91 -PBDT124.93118.45 5 PBT117.87112.95 4 NP91.5291.90 0

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, August 17 2020. 14:12 IST